CEbiotech.com - Central European Biotechnology Portal
be visible on the BioBusiness market                  ISSN 2300-0228
Most popular
searches

News

Show search box
2012-05-30 to 2012-06-01
BioForum 2012. The most important meeting for biotechnology industry in Central Europe. Sum

BioForum 2012. The most important meeting for biotechnology industry in Central Europe. Summary.

On the 23rd-24th of May the biggest and the most important meeting for biotechnology industry in Central Europe was held in Brno in Czech Republic. The event was meant to gather scientists, businessmen, journalists, students and all those who are simply interested in this matter. The representatives ... Read more
Tags bioforum
EFPIA contributes to IMI €223,7 million programme to tackle antibiotic resistance

EFPIA contributes to IMI €223,7 million programme to tackle antibiotic resistance

EFPIA, the voice of the research-based pharmaceutical industry in Europe, welcomes the launch today by the Innovative Medicines Initiative (IMI) public-private partnership, a €223,7 million programme to tackle antimicrobial resistance and to speed up the development of new antibiotics.... Read more
Tags pharma , europe
 Polish biotech company – Mabion co. – sells pharmaceuticals to Northern Africa

Polish biotech company – Mabion co. – sells pharmaceuticals to Northern Africa

Mabion co. – Polish company specialized in medical biotechnology; created to implement research and biosimilar drugs – has recently singed a letter of intent with Sothema Laboratories, company from Marocco, in terms of distribution of the MabionCD20 pharmaceutical in the Maghreb countries (Marocco, A... Read more
Tags biotechnology , poland , pharma
2012-05-14 to 2012-05-15
Directed therapy of Cushing’s disease finally available!

Directed therapy of Cushing’s disease finally available!

We have approached another medical breakthrough: EU has approved the latest Novartis drug – Signifor® – the first pharmaceutical to treat patients with Cushing’s disease. ... Read more
Tags medicine , pharma
Curetis AG Achieves CE-Marking for Unyvero™ Solution and Initiates Commercialization

Curetis AG Achieves CE-Marking for Unyvero™ Solution and Initiates Commercialization

Successful completion of performance evaluation study; CE Mark for Unyvero™ instrument system and pneumonia application... Read more
Tags medicine , pharma
Innovative Medicines Initiative – a public private partnership success story

Innovative Medicines Initiative – a public private partnership success story

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 31 national associations and 35 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 2,000 companies committed ... Read more
Tags bioforum , pharma
2012-05-07 to 2012-05-09
What is the best R&D Team in Central Europe?

What is the best R&D Team in Central Europe?

Nowadays commercialization of scientific knowledge becomes a new branch of industry. Scientists are more and more conscious that their hard-earned intellectual property, besides fame in scientific world could be a source of money and a starting base for innovative business.... Read more
Tags bioforum , biotechnology
Hays Life Sciences HR Survey 2012

Hays Life Sciences HR Survey 2012

Life Sciences Employers are becoming more militant in the battle for talents. It is not only about sourcing the right professionals from the market but most of all creating the work environment to attract and retain them.... Read more
Tags bioforum , czech republic , researches
 How to market the technology to fit the XXI century needs of Molecular Diagnostics

How to market the technology to fit the XXI century needs of Molecular Diagnostics

Molecular diagnostics assess biological makeup at the genetic level. Unlocking DNA code can reveal variations between individuals which may represent a predisposition to develop a disease or even treatment options that may be more effective in some people. To be precise it could be said that molecul... Read more
Tags bioforum , biotechnology , medicine
Sandoz to acquire Fougera Pharmaceuticals, becoming the number one generic dermatology medi

Sandoz to acquire Fougera Pharmaceuticals, becoming the number one generic dermatology medicines company globally and in the US

Novartis has signed a definitive agreement to acquire specialty dermatology generics company Fougera Pharmaceuticals. Under the terms of the agreement, Novartis will acquire the business, which is based in Melville, New York, for USD 1.525 billion in an all-cash transaction.... Read more
Tags pharma
2012-04-23 to 2012-04-26
AMGEN To Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company

AMGEN To Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company

Acquisition Will Build on Amgen’s Existing Business and Provide a Platform for Growth in Turkey and This Strategically Important Region... Read more
Tags pharma , turkey
Industry Opinion: The Success Criteria for the Biotech Industry have changed

Industry Opinion: The Success Criteria for the Biotech Industry have changed

The Danish biotechnology sector has been developed over more than 100 years and long time ago it reached an undisputed high quality level. Despite the financial crisis the Danish biotech sector has the necessary strength to maintain and develop this high quality level in the future... Read more
Tags biotechnology
Regulatory Requirements and European Approval Process of Biosimilar Products from the point

Regulatory Requirements and European Approval Process of Biosimilar Products from the point of EMEA

Biosimilars is a term used to describe officially-approved subsequent versions of innovator biopharmaceutical products. ... Read more
Tags bioforum , biotechnology
BioForum 2012. The most important meeting for biotechnology industry of Central Europe.

BioForum 2012. The most important meeting for biotechnology industry of Central Europe.

On May 23rd-24th the biggest and the most important meeting for biotechnology industry of Central Europe will be held in Brno in Czech Republic. The event is meant to gather scientists, businessmen, journalists, students and all those who are simply interested in this matter. The representatives of t... Read more
Tags bioforum , biotechnology
2012-04-16
 Personalized Medicine: Challenging Pharmaceutical and Diagnostic Company Business Models

Personalized Medicine: Challenging Pharmaceutical and Diagnostic Company Business Models

Despite the dramatic growth in the number and power of molecular diagnostic technologies, the increasing clinical and economic value of the tests derived from them, and the therapeutic power of the drugs whose use can and should be guided by those tests, the reimbursement system for diagnostic tests ... Read more
Tags bioforum , medicine , pharma
2012-04-09 to 2012-04-12
 Aleva Neurotherapeutics Raises CHF 4.0 Million in Series B Financing Round

Aleva Neurotherapeutics Raises CHF 4.0 Million in Series B Financing Round

Lead investor Banexi Ventures Partners joins strong investment consortium... Read more
Tags medicine , pharma
Clinical Trials in Central and Eastern Europe become the global advantage

Clinical Trials in Central and Eastern Europe become the global advantage

Newly developed drugs must be controlled in terms of efficiency and safety. At this step clinical trials are inevitable. They account for the biggest and also the longest part of total cost connected with introduction of new pharmaceuticals to the market. It is estimated that the global market of cli... Read more
Tags medicine , pharma , interview , russia
2012-04-02 to 2012-04-05
Emerging Regenerative Medicine Firm in Czech Republic Chooses CellBase CT

Emerging Regenerative Medicine Firm in Czech Republic Chooses CellBase CT

To Improve Reproducibility and Affordability of their Autologous Cell Therapies... Read more
Tags biotechnology , czech republic , medicine